Biomarkers of exposure and early effect in three contaminated sites of southern Italy: protocols for etiological epidemiological studies.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
10 05 2020
Historique:
entrez: 13 5 2020
pubmed: 13 5 2020
medline: 15 5 2021
Statut: epublish

Résumé

Environmental pollution has been progressively becoming one of the main risk factors to human diseases. In particular, populations living in high-contaminated sites are particularly exposed to environmental toxicants, with consequent increased risks to human health. In Italy, there are currently ongoing three epidemiological etiological studies aimed at evaluating the association between exposure to inorganic and organic chemicals and presence of biological markers of early effects in population living in three National Priority Contaminated Sites (NPCSs). Specifically, the correlations concern preclinical indicators of liver disease in Priolo NPCS, thyroid diseases in Milazzo-Valle del Mela NPCS and cardiovascular risk and kidney damage in Crotone NPCS. Overall, approximately 1300 subjects of both sexes will be enrolled in the three NPCSs according to specific inclusion criteria. For each subject, serum and urine specimens are collected, on which the determination of biological markers of exposure and early effects for the selected outcomes are performed. Individual information on environmental and occupational exposure, medical history, diet and life habits is obtained through questionnaires provided by web platform. In Milazzo-Valle del Mela and Crotone NPCSs, not invasive instrumental and imaging examinations are performed in order to evaluate further risk factors of thyroid carcinoma and cardiovascular disease, respectively. The protocol studies have been approved by the Ethics Committees responsible for the three involved NPCSs: the Ethics Committee 'Catania 2' for the NPCS of Priolo (21 July 2017, n. 500/2017/CECT2), the Ethics Committee of the University Hospitals of Messina for the NPCS of Milazzo-Valle del Mela (19 February 2018, n.2/2018); the Ethics Committee of the Region of Calabria for the NPCS of Crotone (20 July 2017, n. 174). Results will be disseminated among policy-makers, citizens, stakeholders and scientific community through the organisation of conferences and events, and the publication on international peer/reviewed journals.

Identifiants

pubmed: 32393613
pii: bmjopen-2019-036160
doi: 10.1136/bmjopen-2019-036160
pmc: PMC7223157
doi:

Substances chimiques

Biomarkers 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e036160

Informations de copyright

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

J Cancer Epidemiol. 2013;2013:965212
pubmed: 23737785
Int J Mol Sci. 2017 May 12;18(5):
pubmed: 28498320
J Trace Elem Med Biol. 2019 Sep;55:190-195
pubmed: 31345357
G Ital Med Lav Ergon. 2010 Oct-Dec;32(4 Suppl):79-82
pubmed: 21434516
Int J Mol Sci. 2015 Jan 02;16(1):924-49
pubmed: 25561239
BMJ Open. 2019 Jun 12;9(6):e029471
pubmed: 31196906
Am J Epidemiol. 2009 Nov 1;170(9):1156-64
pubmed: 19700501
PLoS One. 2014 Dec 11;9(12):e114908
pubmed: 25502771
Clin J Am Soc Nephrol. 2009 May;4(5):899-906
pubmed: 19406960
Atherosclerosis. 2013 May;228(1):36-7
pubmed: 23484451
Hepatology. 2007 Apr;45(4):846-54
pubmed: 17393509
World J Hepatol. 2016 May 8;8(13):573-90
pubmed: 27168870
Int Urol Nephrol. 2012 Oct;44(5):1487-92
pubmed: 21904850
Hepatology. 2006 Jun;43(6):1317-25
pubmed: 16729309
Curr Diab Rep. 2019 Jun 20;19(7):44
pubmed: 31222515
Toxicology. 2011 May 10;283(2-3):65-87
pubmed: 21414382
Eur Heart J. 2019 Aug 7;40(30):2534-2547
pubmed: 31211361
Curr Pharm Des. 2013;19(13):2390-400
pubmed: 23173588
Vitam Horm. 2014;94:391-425
pubmed: 24388198
Epidemiol Prev. 2019 Jul-Aug;43(4):223-237
pubmed: 31650778
Environ Toxicol. 2017 Apr;32(4):1333-1342
pubmed: 27464007
Environ Health Perspect. 2012 Aug;120(8):a299-301
pubmed: 22853932
Int J Cancer. 2015 Mar 1;136(5):E359-86
pubmed: 25220842
Mol Med Rep. 2017 May;15(5):3413-3419
pubmed: 28339049
BMJ. 2018 Aug 29;362:k3310
pubmed: 30158148
J Hepatol. 2016 Jun;64(6):1388-402
pubmed: 27062661
J Korean Med Sci. 2015 Mar;30(3):272-7
pubmed: 25729249
Epidemiol Prev. 2010 Sep-Dec;34(5-6 Suppl 3):1-2
pubmed: 21220828
Epidemiol Prev. 2019 Mar-Jun;43(2-3 Suppl 1):1-208
pubmed: 31295974
J Toxicol. 2011;2011:870125
pubmed: 21912545
Lancet. 2018 Nov 10;392(10159):1789-1858
pubmed: 30496104
Liver Int. 2015 Sep;35(9):2155-66
pubmed: 25752327
Int J Environ Res Public Health. 2018 Aug 13;15(8):
pubmed: 30104523
J Appl Toxicol. 2011 Mar;31(2):95-107
pubmed: 21321970
Int J Environ Res Public Health. 2019 Sep 18;16(18):
pubmed: 31540358
Clin Endocrinol (Oxf). 2015 Sep;83(3):357-62
pubmed: 25521350
Int J Environ Res Public Health. 2019 Nov 08;16(22):
pubmed: 31717268
Environ Pollut. 2017 Nov;230:320-328
pubmed: 28667913
Med J Aust. 2016 Aug 15;205(4):179-84
pubmed: 27510349
J Gastroenterol Hepatol. 2014 Dec;29(12):2006-13
pubmed: 25039333
Geospat Health. 2016 Apr 18;11(1):320
pubmed: 27087035
J Environ Public Health. 2014;2014:326845
pubmed: 25328531
Dig Dis Sci. 2019 Apr;64(4):910-917
pubmed: 30835028
Am J Kidney Dis. 2008 Mar;51(3):395-406
pubmed: 18295055
Gastroenterology. 2019 Apr;156(5):1264-1281.e4
pubmed: 30660725
Int J Environ Res Public Health. 2018 Aug 24;15(9):
pubmed: 30149577
J Clin Hypertens (Greenwich). 2011 Aug;13(8):621-7
pubmed: 21806773
World J Gastrointest Oncol. 2013 Sep 15;5(9):186-94
pubmed: 24069511
J Clin Endocrinol Metab. 2010 Jun;95(6):3067-72
pubmed: 20357174
Vascul Pharmacol. 2016 Nov;86:77-86
pubmed: 27389001
Circulation. 2019 Sep 10;140(11):e596-e646
pubmed: 30879355
BMC Gastroenterol. 2006 Nov 02;6:33
pubmed: 17081293
Thyroid. 2016 Jan;26(1):1-133
pubmed: 26462967

Auteurs

Francesca Gorini (F)

National Research Council, Institute of Clinical Physiology, Pisa, Italy fgorini@ifc.cnr.it.

Elisa Bustaffa (E)

National Research Council, Institute of Clinical Physiology, Pisa, Italy.

Davide Bolignano (D)

National Research Council, Institute of Clinical Physiology, Reggio Calabria, Italy.

Liliana Cori (L)

National Research Council, Institute of Clinical Physiology, Pisa, Italy.

Francesco Faita (F)

National Research Council, Institute of Clinical Physiology, Pisa, Italy.

Amalia Gastaldelli (A)

National Research Council, Institute of Clinical Physiology, Pisa, Italy.

Monica Interdonato (M)

Department of Clinical and Experimental Medicine, Section of Pharmacology, University of Messina, Messina, Italy.

Fabizio Minichilli (F)

National Research Council, Institute of Clinical Physiology, Pisa, Italy.

Giancarlo Quattrone (G)

Local Health Authority of Messina, Messina, Italy.

Francesco Squadrito (F)

Department of Clinical and Experimental Medicine, Section of Pharmacology, University of Messina, Messina, Italy.

Giovanni Tripepi (G)

National Research Council, Institute of Clinical Physiology, Reggio Calabria, Italy.

Cristina Vassalle (C)

Fondazione CNR-Regione Toscana G Monasterio, Laboratory Medicine Unit, Pisa, Italy.

Fabrizio Bianchi (F)

National Research Council, Institute of Clinical Physiology, Pisa, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH